Please Wait a Moment
X

Articles

17Jun

CTS Dallas and Phoenix Labs Implements WNV Testing on the Panther

17 Jun, 2019 | Return|

CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.

 

 

 

 

Related

VP, Scientific Affairs Dr. Marion Lanteri Speaks at Symposium on Alternatives to Donation Deferral

As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...

Read More >

FDA announces withdrawal of Guidance for ZIKV Testing

We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...

Read More >

Updated WNV Virus Package Insert

We received an updated WNV package insert; please note the manufacturer and license number has been ...

Read More >

Reminder-MD Revised Headers on CTS forms

Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...

Read More >

CTS Tampa Implementation date change for Ultrio Elite

CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...

Read More >

CTS Form Updates 2020

CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...

Read More >